Literature DB >> 32428354

Ultrastructural, transcriptional, and functional differences between human reticulated and non-reticulated platelets.

Laura Hille1, Maximilian Lenz2, Andreas Vlachos2,3, Björn Grüning4, Lutz Hein5,6, Franz-Josef Neumann7, Thomas G Nührenberg1,5,7, Dietmar Trenk1.   

Abstract

BACKGROUND: Reticulated platelets (RP) are the youngest circulating platelets in blood. An increased amount of this subpopulation is associated with higher cardiovascular risk and mortality.
OBJECTIVES: It is unknown to what extent intrinsic properties of RP contribute to their hyperreactive features. This study is the first providing a multifactorial approach based on ultrastructural, transcriptional, and functional analysis of RP compared to non-RP sorted by flow cytometry.
METHODS: Reticulated platelets and non-RP were sorted after platelet staining with SYTO 13. Employing transmission electron microscopy, 1089 micrographs were analyzed for platelet size, amounts of intracellular structures, and anatomical surrogates indicating activation. Long and small RNA-sequencing (RNA-seq) were performed for analyzing differential gene expression. Functional analysis of P-selectin-an upregulated mRNA in RP-was performed in healthy subjects and patients on P2Y12 -inhibitors.
RESULTS: Electron micrographs uncovered distinct ultrastructural differences in RP versus non-RP. Cross sections were 1.9-fold larger in RP (P < .0001). Amounts of α-granules, dense granules, open canalicular system-openings, and mitochondria were increased in RP, which persisted after adjustment for platelet size. Long RNA-seq showed 1212 upregulated transcripts that are predominantly associated to platelet shape change, aggregation, and activation; 1264 mRNAs were downregulated in RP. Small RNA-seq did not reveal any differentially expressed transcripts. Functional analysis displayed higher P-selectin expression as compared to non-RP upon ADP- or TRAP-stimulation.
CONCLUSIONS: Our results demonstrate that altered intrinsic structural and molecular properties contribute to the hyperreactivity of RP. These properties and an increased amount of RP may account for the association with cardiovascular risk.
© 2020 The Authors. Journal of Thrombosis and Haemostasis published by Wiley Periodicals LLC on behalf of International Society on Thrombosis and Haemostasis.

Entities:  

Keywords:  P-selectin; platelet activation; platelet aggregation; transcriptome analysis; transmission electron microscopy

Mesh:

Year:  2020        PMID: 32428354     DOI: 10.1111/jth.14895

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  5 in total

1.  Proteome and functional decline as platelets age in the circulation.

Authors:  Harriet E Allan; Melissa A Hayman; Simone Marcone; Melissa V Chan; Matthew L Edin; Tania Maffucci; Abhishek Joshi; Laura Menke; Marilena Crescente; Manuel Mayr; Darryl C Zeldin; Paul C Armstrong; Timothy D Warner
Journal:  J Thromb Haemost       Date:  2021-08-27       Impact factor: 16.036

2.  Impact of high platelet turnover on the platelet transcriptome: Results from platelet RNA-sequencing in patients with sepsis.

Authors:  Thomas G Nührenberg; Jasmin Stöckle; Federico Marini; Mark Zurek; Björn A Grüning; Vladimir Benes; Lutz Hein; Franz-Josef Neumann; Christian Stratz; Marco Cederqvist; Willibald Hochholzer
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

Review 3.  Hematopoietic responses to SARS-CoV-2 infection.

Authors:  Shokrollah Elahi
Journal:  Cell Mol Life Sci       Date:  2022-03-13       Impact factor: 9.207

Review 4.  The Analysis of the Human Megakaryocyte and Platelet Coding Transcriptome in Healthy and Diseased Subjects.

Authors:  Koenraad De Wispelaere; Kathleen Freson
Journal:  Int J Mol Sci       Date:  2022-07-11       Impact factor: 6.208

Review 5.  Immune-Mediated Platelet Activation in COVID-19 and Vaccine-Induced Immune Thrombotic Thrombocytopenia.

Authors:  Günalp Uzun; Lisann Pelzl; Anurag Singh; Tamam Bakchoul
Journal:  Front Immunol       Date:  2022-02-22       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.